- cafead   Nov 04, 2018 at 02:42: PM
via Disappointing news that Johnson & Johnson (NYSE: JNJ) decided to walk away from a collaboration with Geron Corp. (NASDAQ: GERN) on the latter's only drug, imetelstat, has sent Geron's shares reeling and cast doubt on its future.
article source
article source